Annotated Patent Selections

Bibliography

• EVANS WJ: What is sarcopenia?f aroma (1995) 50A:5–8.
   Google Scholar
• ROUBENOFF R: Inflammatory and hormonal mediators of cachexia. j Nutr (1997) 127:1014S–1016S.
   Google Scholar
• ROUBENOFF R: The pathophysiology of wasting in the elderly. J. Nutr (1999) 129:256S–259S.
   Google Scholar
• ROUBENOFF R, CASTANEDA C: Sarcopenia - understanding the dynamics of aging muscle. JAMA (2001) 286:1230–1231.
   PubMed Web of Science ®Google Scholar
• LAMBERTS SWJ, VAN DEN BELD AW, VAN DER LELY A-J: The endocrinology of aging. Science (1997) 278:419–424.
   PubMedGoogle Scholar
• TSENG BS, MARSH DR, HAMILTON MT, BOOTH FW: Strength and aerobic training attenuate muscle wasting and improve resistance to the development of disability with aging. J. Gerantal. (1995) 50A:113–119.
   Google Scholar
• BROOKS SV, FAULKNER JA: Skeletal muscle weakness in old age: underlying mechanisms. Med. Sci. Sports Exerc. (1994) 46:B28–B33.
   Google Scholar
• LARSSON L, ANSVED T: Effects of ageing on the motor unit. Frog. Neurobial. (1995) 45:397–458.
   PubMed Web of Science ®Google Scholar
• ••Excellent review on age-related changes toskeletal muscle function.
   Google Scholar
• LARSSON L, RAMAMURTHY B: Aging-related changes in skeletal muscle. Drugs Aging (2000) 17:303–316.
   PubMed Web of Science ®Google Scholar
• MASORO EJ: Aging. In: Handbook of Physiology, Section 11. Masoro EJ (Ed.) Oxford University Press, New York, USA (1995):681.
   Google Scholar
• ••Definitive volume describing physiologicalchanges to body systems as a consequence of age.
   Google Scholar
• MORLEY JE, BAUMGARTNER RN, ROUBENOFF R, MAYER J, NAIR KS: Sarcopenia. J. Lab. Clin. Med. (2001) 137:231–243.
   PubMed Web of Science ®Google Scholar
• NAVARRO A, LOPEZ-CEPERO J, SANCHEZ DEL PINO MJ: Skeletal muscle aging. Front. Biosci. (2001) 6:D26–D44.
   PubMed Web of Science ®Google Scholar
• FAULKNER JA, BROOKS SV, ZERBA E: Muscle atrophy and weakness with aging: Contraction-induced injury as an underlying mechanism. J Gerantol. (1995) 50A:124–129.
   Google Scholar
• ROOS MR, RICE CL, VANDERVOORT AA: Age-related changes in motor unit function. Muscle Nerve (1997) 20:679–690.
   PubMed Web of Science ®Google Scholar
• LYNCH GS, HINKLE RT, BROOKS SV, CHAMBERLAIN JS, FAULKNER JA: Force and power output of fast and slow skeletal muscles from old dystrophic Inds mice. J Physid. (Land) (2001) 535:591–600.
   PubMed Web of Science ®Google Scholar
• BOOTH FW, WEEDEN SH, TSENG BS: Effect of aging on human skeletal muscle and motor function. Med. Li. Sports Exerc. (1994) 26:556–560.
   PubMed Web of Science ®Google Scholar
• EINSIEDEL LJ, LUFF AR: Alterations in the contractile properties of motor units within the aging rat medial gastrocnemius. Neural Li. (1992) 112:170–177.
   Google Scholar
• LEXELL J, TAYLOR CC, SJOSTROM M: What is the cause of the ageing atrophy? J. Neural Sci. (1988) 84:275–294.
   PubMed Web of Science ®Google Scholar
• LEXELL J, DOWNHAM D: What determines the muscle cross-sectional area? J Neural Li. (1992) 111:113–114.
   Google Scholar
• LEXELL J: Human aging, muscle mass and fiber type composition. J. aroma (1995) 50A:11–16.
   Google Scholar
• LEXELL J: Strength training and muscle hypertrophy in older men and women. Top. Geriatr. Rehabil. (2000) 15:41–46.
   Web of Science ®Google Scholar
• LEXELL J: Evidence for nervous system degeneration with advancing age. J. Nutr (1997) 127:1011S–1013S.
   Google Scholar
• DOHERTY TJ, VANDERVOORT AA, BROWN WF: Effects of ageing on the motor unit: a brief review. Can. J. Appl. Physial (1993) 18:331–358.
   PubMedGoogle Scholar
• LUFF AR: Age-associated changes in the innervation of muscle fibers and changes in the mechanical properties of motor units. Annals. New York Acad. Sci. (1998) 854:92–101.
   PubMed Web of Science ®Google Scholar
• CHAN KM, DOHERTY TJ, BROWN WF: Contractile properties of human motor units in health, aging and disease. Muscle Nerve (2001) 24:1113–1133.
   PubMed Web of Science ®Google Scholar
• SCHULTZ AB, ASHTON-MILLER JA, ALEXANDER NB: What leads to age and gender differences in balance maintenance and recovery. Muscle Nerve (2001) (Suppl. 5):560–564.
   Google Scholar
• LARSSON L, EDSTROM L: Effects of age on enzyme-histochemical fibre spectra and contractile properties of fast- and slow-twitch skeletal muscles in the rat. J. Neural Sci. (1986) 76:69–89.
   PubMed Web of Science ®Google Scholar
• NARAYANAN N, JONES DL, XU A, YU JC: Effects of aging on sarcoplasmic reticulum function and contraction duration in skeletal muscles of the rat. Am. Physial (1996) 271:C1032–C1040.
   PubMed Web of Science ®Google Scholar
• GONZALEZ E, MESSI ML, DELBONO O: The specific force of single intact extensor digitorum longus and soleus mouse muscle fibers declines with aging. J. Memb. Biol. (2000) 178:175–183.
   PubMedGoogle Scholar
• LARSSON L, LI X, FRONTERA WR: Effects of aging on shortening velocity and myosin isoform composition in single human skeletal muscle cells. Am. I Physial (1997) 272:C638–C649.
   Google Scholar
• PLANT DR, LYNCH GS: Rigor force responses of permeabilized fibres from fast and slow skeletal muscles of aged rats. Chit. Exp. Pharm. Physial (2001) 28:779–781.
   PubMedGoogle Scholar
• TRAPPE S, GODARD M, GALLAGHER E CARROLL C, ROWDEN G, PORTER D: Resistance training improves single muscle fiber contractile function in older women. Am. I Physial (2001) 281:C398–C406.
   Web of Science ®Google Scholar
• KRIVICKAS LS, SUH DW, WILKINS J, HUGHES VA, ROUBENOFF R, FRONTERA WR: Age- and gender-related differences in maximum shortening velocity of skeletal muscle fibers. Am. I Phys. Med. Rehabil. (2001) 80:447–455.
   PubMed Web of Science ®Google Scholar
• HOOK P, SRIRAMOJU V, LARSSON L: Effects of aging on actin sliding speed on myosin from single skeletal muscle cells of mice, rats and humans. Am. I Physial (2001) 280:C782–C788.
   Google Scholar
• BROOKS SV, FAULKNER JA: Contractileproperties of skeletal muscles from young, adult and aged mice. I Physial (1988) 404:71–82.
   PubMed Web of Science ®Google Scholar
• PHILLIPS SK, WISEMAN RW, WOLEDGE RC, KUSHMERICK MJ: Neither changes in phosphorus metabolite levels nor myosin isoforms can explain the weakness in aged mouse muscle. I Physial (1993) 463:157–167.
   PubMed Web of Science ®Google Scholar
• FITTS RH, TROUP JP, WITZMAN FA, HOLLOSZY JO: The effect of aging and exercise on skeletal muscle function. Mech. Ageing Dev. (1984) 27:161–172.
   PubMed Web of Science ®Google Scholar
• BROWN M, HASSER EM. Complexity of age-related change in skeletal muscle. Get-onto]. (1996) 51A:B117–B123.
   Google Scholar
• VOLPI E, SHEFFIELD-MOORE M, RASMUSSEN BB, WOLFE RR: Basal muscle amino acid kinetics and protein synthesis in healthy young and older men. JAMA (2001) 286:1206–1212.
   PubMed Web of Science ®Google Scholar
• HASTEN DL, PAK-LODUCA J, OBERT KA, YARASHESKI KE: Resistance exercise acutely increases MHC and mixed muscle protein synthesis rates in 78-84 and 23-32 yr olds. Am. I Physial (2000) 278:E620–E626.
   PubMed Web of Science ®Google Scholar
• YARASHESKI KE, PAK-LODUCA J, HASTEN DL, OBERT KA, BROWN M, SINACORE DR: Resistance exercise training increases mixed muscle protein synthesis rate in frail women and men 76 yr old. Am. J. Physial (1999) 277:E118–E125.
   PubMed Web of Science ®Google Scholar
• WELLE S, THORNTON C, STATT M: Myofibrillar protein synthesis in young and old human subjects after three months of resistance training. Am. I Physial (1995) 31:E422–E427.
   Google Scholar
• THOMPSON LV: Contractile properties and protein isoforms of single skeletal muscle fibers from 12-and 30-month-old Fischer 344 Brown Norway Fl hybrid rats. Aging Chit. Exp. Res. (1999) 11:109–118.
   PubMedGoogle Scholar
• THOMPSON LV, BROWN M: Age-related changes in contractile properties of single skeletal fibers from the soleus muscle. Appl. Physial. (1999) 86:881–886.
   PubMed Web of Science ®Google Scholar
• FRONTERA WR, SUH D, KRIVICKAS LS, HUGHES VA, GOLSTEIN R, ROUBENOFF R. Skeletal muscle fiber quality in older men and women. Am. Physial (2000) 279:C611–C618.
   PubMed Web of Science ®Google Scholar
• WIDRICK JJ, KNUTH ST, NORENBERG KM et al.: Effect of 17-day spaceflight on contractile properties of human soleus muscle fibers. I Physial (1999) 516:915–930.
   PubMed Web of Science ®Google Scholar
• TRAPPE S, WILLIAMSON D, GODARD M, PORTER D, ROWDEN G, COSTILL D: Effect of resistance training on single muscle fiber contractile function in older men. I Appl. Physial (2000) 89:143–152.
   PubMed Web of Science ®Google Scholar
• WANG Z-M, MESSI ML, DELBONO O: L-type Ca2+ channel charge movement and intracellular Ca2+ in skeletal muscle fibers from aging mice. Biophys. 1 (2000) 78:1947-1954.
   Google Scholar
• MARGRETH A, DAMIANI E, BORTOLOSO E: Sarcoplasmic reticulum in aged skeletal muscle. Acta Physial Stand. (1999) 167:331–338.
   PubMedGoogle Scholar
• DELBONO O, O'ROURKE KS, ETTINGER WH: Excitation-calcium release uncoupling in aged single human skeletal muscle fibers. J. Memb. Biol. (1995) 148:211–222.
   PubMedGoogle Scholar
• DAMIANI E, LARSSON L, MARGRETH A: Age-related abnormalities in regulation of the ryanodine receptor in rat fast-twitch muscle. Cell Calcium (1996) 19:15–27.
   PubMed Web of Science ®Google Scholar
• FERRINGTON DA, KRAINEV AG, BIGELOW DJ: Altered turnover of calcium regulatory proteins of the sarcoplasmic reticulum in aged skeletal muscle. I Biol. Chem. (1998) 273:5885–5891.
   Google Scholar
• PROCTOR DN, BALAGOPAL P, NAIR KS: Age-related sarcopenia in humans is associated with reduced synthetic rates of specific muscle proteins. J. Nutt: (1998) 128:351S–355S.
   Google Scholar
• HEDSTROM M: Hip fracture patients, agroup of frail elderly people with low bone mineral density, muscle mass and IGF-I levels. Acta Physial Stand. (1999) 167:347–350.
   PubMedGoogle Scholar
• LYNCH GS, FAULKNER JA: Contraction-induced injury to single muscle fibers: Velocity of stretch does not influence the force deficit. Am. J. Physial (1998) 275:C1548–C1554.
   Google Scholar
• BALAGOPAL P, PROCTOR D, NAIR KS: Sarcopenia and hormonal changes. Endocrine (1997a) 7:57–60.
   PubMed Web of Science ®Google Scholar
• BALAGOPAL P, ROOYACKERS OE, ADEY DB, ADES PA, NAIR KS: Effects of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans. Am. J. Physial (1997b) 36:E790–E800.
   Google Scholar
• BALAGOPAL P, SCHIMKE JC, ADES P, ADEY D, NAIR KS: Age effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise. Am. j Physial (2001) 280:E203–E208.
   Google Scholar
• YARASHESKI KE, ZACHWIEJA JJ, BIERDM: Acute effects of resistance exercise on muscle protein synthesis rate in young and elderly men and women. Am. j Physial (1993) 265:E 210–E214.
   Google Scholar
• WELLE S, THORNTON C, STATT M: Myofibrillar protein synthesis in young and old human subjects after three months of resistance training. Am. j Physial. (1995) 268:E422–E427.
   Google Scholar
• SCHWARTZ RS: Trophic factor supplementation: Effects on age-associated changes in body composition. j Gerontology (1995) 50A:151–156.
   Google Scholar
• •Good introduction to the basis of growth factor treatments for sarcopenia.
   Google Scholar
• BARAZZONI R, NAIR, KS: Sarcopenia ofthe elderly. Diab. Num. Metall. (2000) 13:92–98.
   PubMedGoogle Scholar
• FRONTERA WR, MEREDITH CN, O'REILLY KP, KNUTTGEN HG, EVANS WJ: Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J Am/. Physial (1988) 64:1038–1044.
   Google Scholar
• FRONTERA WR, HUGHES VA, FIELDING RA, FIATARONE MA, EVANS WJ, ROUBENOFF R: Aging of skeletal muscle: a 12-yr longitudinal study. Appl. Physial (2000) 88:1321–1326.
   PubMed Web of Science ®Google Scholar
• FIATARONE MA, MARKS EC, RYAN ND, MEREDITH CN, LIPSITZ LA, EVANS WJ: High-intensity strength training in nonagenarians: Effects on skeletal muscle. JAMA (1990) 263:3029–3034.
   PubMed Web of Science ®Google Scholar
• MORGANTI CM, NELSON ME, FIATARONE MA et al: Strength improvements with 1 year of progressive resistance training in older women. Med. Sri. Sports Ever (1995) 27:906–912.
   PubMedGoogle Scholar
• MAZZEO RS, CAVANAGH P, EVANS WJ etal.: Exercise and physical activity for older adults. Med. Sri. Sports Exer. (1998) 30:992–1008.
   PubMed Web of Science ®Google Scholar
• McCARTNEY N, HICKS AL, MARTIN J,WEBBER CE: A longitudinal trial of weight training in the elderly - continued improvements in Year 2.1 Ceram-al. (1996) 51:B425–B433.
   Google Scholar
• ALEXANDER NB, SCHULTZ AB, ASHTON MILLER JA, GROSS MM, GIORDANI B: Muscle strength and rising from a chair in older adults. Muscle Nerve (1997) (Suppl. 5):S56–S59.
   Google Scholar
• ALEXANDER NB, GROSS MM, MEDELL JL, HOFMEYER MR: Effects of functional ability and training on chair-rise biomechanics in older adults. I Ceram-al. (2001) 56:M538–M547.
   Google Scholar
• YARASHESKI KE, PAK-LODUCA J, HASTEN DL, OBERT KA, BROWN ME, SINACORE DR: Resistance exercise training increases mixed muscle protein synthesis rate in frail women and men 76 yr old. Am. J. Physial. (1999) 277:E118–E125.
   PubMed Web of Science ®Google Scholar
• GURWITZ D: Are drug targets missed owing to lack of physical activity? Drug Disc. Today (2001) 6:342–343.
   Google Scholar
• BOOTH FW, GORDON SE, CARLSON CJ, HAMILTON MT: Waging war on modern chronic diseases: primary prevention through exercise biology. I Appl. Physial (2000) 88:774–787.
   PubMed Web of Science ®Google Scholar
• •Presents strong argument for the role and promotion of exercise science in health and disease research.
   Google Scholar
• ANDERSON B: Are drug targets missed due to lack of physical activity? - Reply. Drug Disc. Today (2001) 6:515.
   PubMedGoogle Scholar
• GURWITZ D: Are drug targets missed owing to lack of physical activity? - Reply. Drug Disc. Today (2001) 6:564–565.
   PubMedGoogle Scholar
• LYNCH GS: Novel therapies for muscular dystrophy and other muscle wasting conditions. Expert Opin. Ther. Patents (2001) 11(4):587–601.
   Web of Science ®Google Scholar
• YARASHESKI KE. ZACHWIEJA JJ. Growth hormone therapy for the elderly - the fountain of youth proves toxic. JAMA (1993) 270:1694.
   PubMedGoogle Scholar
• YARASHESKI KE, ZACHWIEJA JJ, ANGELOPOULOS TJ, BIER DM: Short-term growth hormone treatment does not increase muscle protein synthesis in experienced weight lifters. I Appl. Physial (1993) 74:3073–3076.
   PubMedGoogle Scholar
• YARASHESKI KE, ZACHWIEJA JJ, CAMPBELL JA, BIER DM: Effect of growth hormone and resistance exercise on muscle growth and strength in older men. Am. J. Physial. (1995) 268:E268–E276.
   Google Scholar
• YARASHESKI KE, CAMPBELL JA, KOHRT WM: Effect of resistance exercise and growth hormone on bone density in older men. Clin. Enderlin (1997) 47:223–229.
   PubMedGoogle Scholar
• ZACHWIEJA JJ, TOFFOLO G, COBELLI C, BIER DM, YARASHESKI KE: Resistance exercise and growth hormone administration in older men - effects on insulin sensitivity and secretion during a stable-label intravenous glucose tolerance test. Metall. CM]. Exp. (1996) 45:254–260.
   Google Scholar
• WELLE S, THORNTON C, STATT M, McHENRY B: Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old. I CM]. Enderlin. Metall. (1996) 81:3239–3243.
   Google Scholar
• WELLE S, THORNTON C: Insulin-like growth factor-I, actin and myosin heavy chain messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old. I Enderlin (1997) 155:93–97.
   Google Scholar
• ROUBENOFF R, RALL LC, VELDHUIS JD et al.: The relationship between growth hormone kinetics and sarcopenia in postmenopausal women: the role of fat mass and leptin. I Clirr. Endo. Metall. (1998) 83:1502–1506.
   PubMed Web of Science ®Google Scholar
• MOXLEY RT: Potential for growth factor treatment of muscle disease. Curr. Opin. Neural (1994) 7:427–434.
   PubMed Web of Science ®Google Scholar
• HANTAI D, AKAABOUNE M, LAGORD C et al.: Beneficial effects of insulin-like growth factor-1 on wobbler mouse motoneuron disease. I Neural Li. (1995) 129:S122–S126.
   Google Scholar
• BACH LA: The insulin-like growth factor system: basic and clinical aspects. Aust. NZ Med. (1999) 29:355–361.
   PubMedGoogle Scholar
• BAXTER RC: Insulin-like growth factor (IG9-binding proteins: interactions with IGFs and intrinsic bioactivities. Am. Physial. (2000) 278:E967–E976.
   Google Scholar
• KETTLEHUT I, WING SS, GOLDBERG A: Endocrine regulation of protein breakdown in skeletal muscle. Diab. Rev (1988) 4:751–772.
   PubMedGoogle Scholar
• WINGERTZAHN MA, ZDANOWICZ MM, SLONIM AE: IGF-1 and high protein diet decrease calpain-mediated proteolysis in murine muscular dystrophy. Proc. Soc. Exp. Biol. Med. (1998) 218:244–250.
   PubMed Web of Science ®Google Scholar
• ZDANOWICZ MM, TEICHBERG S, O'CONNOR M, MOYSE J, SLONIM AE: Metabolic and structural effects of insulin-like growth factor-I and high-protein diet on dystrophic hamster skeletal muscle. Proc. Soc. Exp. Biol. Med. (1997) 215:168–173.
   PubMedGoogle Scholar
• HOBLER SC,. WILLIAMS AB, FISCHER JE, HASSELGREN PO: IGF-I stimulates protein synthesis but does not inhibit protein breakdown in muscle from septic rats. Am. J. Physial (1998) 43:R571–R576.
   Google Scholar
• KANDA F, TAKATANI K, OKUDA S, MATSUSHITA T, CHIHARA K: Preventive effects of insulinlike growth factor-I on steroid-induced muscle atrophy. Muscle Nerve (1999) 22:213–217.
   PubMed Web of Science ®Google Scholar
• CRIS WELL DS, POWERS SK, HERB RA,DODD SL: Mechanism of specific force deficit in the senescent rat diaphragm. Resp. Physial (1997) 107:149–155.
   PubMedGoogle Scholar
• GROSSMAN EJ, GRINDELAND RE, ROY RR, TALMADGE RJ, EVANS J, EDGERTON VR: Growth hormone, IGF- I and exercise effects on non-weight-bearing fast muscles of hypophysectomized rats. Appl. Physial (1997) 83:1522–1530.
   PubMedGoogle Scholar
• LEWIS MI, FEINBERG AT, FOURNIER M: IGF-I and/or growth hormone preserve diaphragm fiber size with moderate malnutrition. j Appl. Physial (1998) 85:189–197.
   Google Scholar
• ROY RR, TRI C, GROSSMAN EJ et al:IGF-I, growth hormone and/or exercise effects on non-weight bearing soleus of hypophysectomized rats. j Appl. Physial (1996) 81:302–311.
   Google Scholar
• LO H-C, HINTON PS, YANG H, UNTERMAN TG, NEY DM: Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats. j Paren. Ent. Num. (1996) 20:171–177.
   PubMedGoogle Scholar
• BORST SE, LOWENTHAL DT: Role of IGF-I in muscular atrophy of aging. Endocrinology (1997) 7:61–63.
   Google Scholar
• ADAMS GR: Insulin-like growth factor in muscle growth and its potential abuse by athletes. Br. I Spornmed. (2000) 34:412–413.
   PubMed Web of Science ®Google Scholar
• CHAKRAVARTHY MV, DAVIS BS, BOOTH FW: IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. I Appl. Physial (2000) 89:1365–1379.
   PubMed Web of Science ®Google Scholar
• KELLER HL, SCHNEIDER BSP, EPPIHIMER LA, CANNON JG: Association of IGF-I and IGF-II with myofiber regeneration in vivo. Muscle Nerve (1999) 22:347–354.
   PubMedGoogle Scholar
• MACGREGOR J, PARKHOUSE WS: The potential role of insulin-like growth factors in skeletal muscle regeneration. Can. Appl. Physial. (1996) 21:236–250.
   PubMedGoogle Scholar
• BARTON-DAVIS ER, SHOTURMA DI, MUSARO A, ROSENTHAL N, SWEENEY HL: Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. PNAS (1998) 95:15603–15607.
   PubMed Web of Science ®Google Scholar
• •Describes the potential for IGF-I to ameliorate age-related changes to skeletal muscle.
   Google Scholar
• SEMSARIAN C, WU MJ, YU YK et al.: Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature (1999) 400:576–581.
   PubMed Web of Science ®Google Scholar
• MUSARO A, McCULLAGH KJA, NAYA FJ, OLSON EN, ROSENTHAL N: IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-Tcl. Nature (1999) 400:581–585.
   PubMedGoogle Scholar
• •Describes mechanism of action of IGF-I induced hypertrophy of skeletal muscle.
   Google Scholar
• MUSARO A. McCULLAGH KJA, PAUL A et al: Localized IGF-1 transgene sustains hypertrophy and regeneration in senescent muscle. Nat. Gen. (2001) 27:195–200.
   PubMedGoogle Scholar
• STANDKER L, BRAULKE T, MARK S et al.: Partial IGF affinity of circulating N-and C-terminal fragments of human insulin-like growth factor binding protein-4 (ICFBP-4) and the disulfide bonding pattern of the C-terminal IGFBP-4 domain. Biochem. (2000) 39:5082–5088.
   PubMedGoogle Scholar
• CHEIN E, GONZALEZ MJ, RIORDAN NH: Retrospective analysis of the effects of low-dose, high frequency human growth hormone on serum lipids and prostate specific antigen. j Am. Aging Assoc. (2001) 24:59–62.
   PubMedGoogle Scholar
• MONTGOMERY HE, CLARKSON P, DOLLERY CM et al: Association of angiotensin-converting enzyme gene i/d polymorphism with change in left ventricular mass in response to physical training. Circulation (1997) 96:741–747.
   PubMed Web of Science ®Google Scholar
• GHIGO E, ARVAT E, GIORDANO R et al.: Biologic activities of growth hormone secretagogues in humans. Endocrine (2001) 14:87–93.
   PubMed Web of Science ®Google Scholar
• PAPOTTI M, GHE C, CASSONI Petal.: Growth hormone secretagogue binding sites in peripheral human tissues. j Chit. Endocnn. Metab. (2000) 85:3803–3807.
   Google Scholar
• KENNEDY JH, BOWERS JL, DODGE JA, LUGAR CW, SHEPHERD TA, SHARP VS: Development of analytical and preparative chromatographic separations of novel growth hormone secretagogue compounds. j Chromat. (2000) 872:75–84
   Google Scholar
• FUH VL, BACH MA: Growth hormone secretagogues - mechanism of action and use in aging. Growth Hormone & ICF Res. (1998) 8:13–20.
   PubMed Web of Science ®Google Scholar
• BERCU BB, WALKER RF: Novel growth hormone secretagogues - clinical applications. Endocrinologist (1997) 7:51–64.
   Google Scholar
• FEIGHNER SD, TAN CP, McKEE la et al.: Receptor for motilin identified in the human gastrointestinal system. Science (1999) 284:2184–2188.
   PubMed Web of Science ®Google Scholar
• FREIDINGER RM: Nonpeptidic ligands for peptide and protein receptors. Cun: Opin. Chem. Biol. (1999) 3:395–406.
   PubMedGoogle Scholar
• LECHAN RIVI, TATRO JB: Editorial: Hypothalamic melanocortin signaling in cachexia. Endocrinology (2001) 142:3288–3291.
   PubMedGoogle Scholar
• GUILLET C, AUGUSTE P, MAYO W, KREHER P, GASCAN H: Ciliary neurotrophic factor is a regulator of muscular strength in aging. I Neurosci. (1999) 19:1257–1262.
   Google Scholar
• ROTH SM, SCHRAGER MA, FERRELL RE et al.: CNTF genotype is associated with muscular strength and quality in humans across the adult age span. I Appl. Physial (2001) 90:1205–1210.
   PubMed Web of Science ®Google Scholar
• ROBERTSON A, DAY B, POLLOCK M, COLLIER P: The neuropathy of elderly mice. Acta Neurapathol. (1993) 86:163–171.
   PubMed Web of Science ®Google Scholar
• VERDU E, CEBALLOS D, VILCHES JJ, NAVARRO X: Influence of aging on peripheral nerve function and regeneration. J. Peripheral Nervous Sys. (2000) 5:191–208.
   PubMed Web of Science ®Google Scholar
• AKKINA SK, PATTERSON CL, WRIGHT DE: GDNF rescues nonpeptidergic unmyelinated primary afferents in streptozotocin-treated diabetic mice. Exp. Neural (2001) 167:173–182.
   PubMedGoogle Scholar
• QUINN LS, HAUGK KL, GRABSTEIN KH: Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology (1995) 136:3669–3672.
   PubMed Web of Science ®Google Scholar
• QUINN LS, HAUGK KL, DAMON SE: IL-15 stimulates C2 skeletal myoblast differentiation. Biochem. Biophys. Res. Comm. (1997) 239:6–10.
   PubMedGoogle Scholar
• CARBO N, LOPEZ-SORIANO J, COSTELLI P et al.: Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br. I Cancer (2000) 83:526–531.
   PubMed Web of Science ®Google Scholar
• GREGOREVIC P, WILLIAMS DA, LYNCH, GS: Effects of LIF on rat skeletal muscles are modulated by clenbuterol. Muscle & Nerve (2001) 25: In Press.
   Google Scholar
• MOUSSAD EEDA, BRIGSTOCK DR: Connective tissue growth factor: What's in a name? Mal. Genet. Metab. (2000) 71:276–292.
   PubMedGoogle Scholar
• LYNCH GS, CUFFE SA, PLANT DR, GREGOREVIC P: IGF-I treatment improves the functional properties of fast-and slow-twitch skeletal muscles from dystrophic mice. Neuromus. Dis. (2001) 11:260–268.
   PubMed Web of Science ®Google Scholar
• WALLACE JD, CUNEO RC: Growth hormone abuse in athletes: A review. Endocrinologist (2000) 10:175–184.
   Google Scholar
• LYNCH GS: Beta agonists. In: Performance Enhancing Substances in Sport and Exercise. Bahrke M, Yesalis CE (Eds), Human Kinetics, Champaign IL, (2001):In Press.
   Google Scholar
• VLACHOPAPADOPOULOU E, ZACHWIEJA JJ etal.: Metabolic and clinical response to recombinant human insulin-like growth factor Tin myotonic dystrophy- a clinical research center study. J. OM. Endocrine]. Metab. (1995) 80: 3715–3723.
   Google Scholar
• CUNEO RC: Issues regarding growth hormone replacement in growth hormone deficient adults. Aust. NZ Med. (1999) 29:289–291.
   PubMedGoogle Scholar
• •Provides good description of issues regarding clinical use of GH and related compounds.
   Google Scholar
• TARNOPOLSKY MA, BEAL MF: Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Annals Neural (2001) 49:561–574.
   PubMed Web of Science ®Google Scholar
• KING DS, SHARP RL, VUKOVICH MD et al.: Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men - A randomized controlled trial. JAMA (1999) 281:2020–2028.
   PubMed Web of Science ®Google Scholar
• BROWN GA, VUKOVICH MD, REIFENRATH TA et al: Effects of anabolic precursors on serum testosterone concentrations and adaptations to resistance training in young men. Int. J. Sport Num (2000) 10:340–359.
   PubMed Web of Science ®Google Scholar
• RASMUSSEN BB, VOLPI E, GORE DC, WOLFE RR: Androstenedione does not stimulate muscle protein anabolism in young healthy men. J. Clin Endo. Metab. (2000) 85:55–59.
   PubMed Web of Science ®Google Scholar
• BALLANTYNE CS, PHILLIPS SM, MACDONALD JR, TARNOPOLSKY MA, MACDOUGALL JD: The acute effects of androstenedione supplementation in healthy young males. Can. J. Appl. Physial (2000) 25:68–78.
   PubMedGoogle Scholar
• BROEDER CE, QUINDRY J, BRITTINGHAM K etal.: The andro project - physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program. Arch. Intern. Med. (2000) 160:3093–3104.
   Google Scholar
• MALTIN CA, DELDAY MI, WATSON JS et al: Clenbuterol, a P-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. OM. Sci (1993) 84:651–654.
   Google Scholar
• LYNCH GS, HINKLE RT, FAULKNER JA: Year-long treatment with clenbuterol increases muscle mass but not force or power output of skeletal muscles of mice. CM]. Exp. Pharm. Physial (1999) 26:117–120.
   PubMedGoogle Scholar
• LYNCH GS, HINKLE RT, FAULKNER JA: Power output of skeletal muscles of control and Indy (dystrophic) mice after clenbuterol treatment. Exp. Physial (2000) 85:294–298.
   Google Scholar
• LYNCH GS, HINKLE RT, FAULKNER JA: Force and power output of diaphragm muscle strips from Indy and control mice after clenbuterol treatment. Neuromus. Dis. (2001) 11:191–195.
   Google Scholar
• CHEN KJD, ALWAY SE: A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats. J. Appl. Physial (2000) 89:606–612.
   Google Scholar
• DUNLOP J, ROSENZWEIG-LIPSON S: Therapeutic approaches to obesity. Expert Opin. Ther. Patents (1998) 8(12):1683–1694.
   Web of Science ®Google Scholar
• McPHERRON AC, LAWLER AM, LEE SJ: Regulation of skeletal muscle mass in mice by a new TGF-I3 superfamily member. Nature (1997) 387:83–90.
   PubMed Web of Science ®Google Scholar
• LEE SJ, McPHERRON AC: Myostatin and the control of skeletal muscle mass. Curr. Opin. Genet. Dev. (1999) 9:604–607.
   PubMed Web of Science ®Google Scholar
• LEE SJ, McPHERRON AC: Regulation of myostatin activity and muscle growth. PNAS (2001) 98:9306–9311.
   PubMed Web of Science ®Google Scholar
• GONZALEZ-CADAVID NF, TAYLOR WE, YARASHESKI K et al.: Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. PNAS (1998) 95:14938–14943.
   PubMed Web of Science ®Google Scholar
• SEIBERT MJ, XUE Q-L, FRIED LP WALSTON JD: Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the women's health and aging study II cohort. J. Am. Ceriatr. Soc. (2001) 49:1093–1096.
   Google Scholar
• McDONALD T, WANG RP BAILEY Wet al.: Identification and cloning of an orphan G protein-coupled receptor of the glycoprotein hormone receptor subfamily. Biochem. Biophys. Res. Comm. (1998) 247:266–270.
   Google Scholar
• KIM DG, CHI SS, LEE KH et al: Neuregulin stimulates myogenic differentiation in an autocrine manner. J. Biol. Chem. (1999) 274:15395–15400.
   PubMed Web of Science ®Google Scholar
• SUAREZ E, BACH D, CADEFAU J, PALACIN M, ZORZANO A, GUMA A: A novel role of neuregulin in skeletal muscle - Neuregulin stimulates glucose uptake, glucose transporter translocation and transporter expression in muscle cells. _J. Biol. Chem. (2001) 276:18257–18264.
   PubMedGoogle Scholar
• FROMM L, BURDEN SJ: Synapse specific and neuregulin-induced transcription requires an Ets site that binds GABP-aGABP-P. Genes Dev (1998) 12:3074–3083.
   PubMedGoogle Scholar
• COHEN P: The development and therapeutic potential of protein kinase inhibitors. Curr. Opin. Chem. Biol. (1999) 3:459–465.
   PubMed Web of Science ®Google Scholar
• TERJUNG RL, CLARKSON P, EICHNER ER etal.: The physiological and health effects of oral creatine supplementation. Med. Sci. Sports Exerc. (2000) 32:706–717.
   PubMed Web of Science ®Google Scholar
• RAWSON ES, WEHNERT ML, CLARKSON PM: Effects of 30 days of creatine ingestion in older men. Eur. j Appl. Physial. (1999) 80:139–144.
   PubMed Web of Science ®Google Scholar
• PARISE G, MIHIC S, MACLENNAN D, YARASHESKI KE, TARNOPOLSKY MA: Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. J. Appl. Physial. (2001) 91:1041–1047.
   PubMed Web of Science ®Google Scholar
• WILLOUGHBY DS, ROSENE J: Effects of oral creatine and resistance training on myosin heavy chain expression. Med. Li. Sports Exerc. (2001) 33:1674–1681.
   PubMed Web of Science ®Google Scholar
• BERMON S, VENEMBREP, SACHET C, VALOUR S, DOLISI C: Effects of creatine monohydrate ingestion in sedentary and weight-trained older adults. Acta Physial Scam/. (1998) 164:147–155.
   PubMedGoogle Scholar
• JAKOBI JM, RICE CL, CURTIN SV, MARSH GD: Neuromuscular properties and fatigue in older men following acute creatine supplementation. Eur. j Appl. Physiol. (2001) 84:321–328.
   PubMed Web of Science ®Google Scholar
• SLATER GJ, JENKINS D: P-hydroxy-P-methylbutyrate (HMB) supplementation and the promotion of muscle growth and strength. Sports Med (2000) 30:105–116.
   PubMed Web of Science ®Google Scholar
• KNITTER AE, PANTON L, RATHMACHER JA, PETERSEN A, SHARP R: Effects of P-hydroxy-P-methylbutyrate on muscle damage after a prolonged run. J. Appl. Physiol. (2000) 89:1340–1344.
   PubMed Web of Science ®Google Scholar
• VUKOVICH MD, STUBBS NB, BOHIKEN RM: Body composition in 70-year-old adults responds to dietary 13-hydroxy-P-methylbutyrate similarly to that of young adults. J. Num (2001) 131:2049–2052.
   Google Scholar
• CLARK RH, FELEKE G, DIN M et al: Nutritional treatment for acquired immunodeficiency virus-associated wasting using P-hydroxy P-methylbutyrate, glutamine and arginine: A randomized, double-blind, placebo-controlled study. J. Parer]. Ent. Num (2000) 24:133–139.
   PubMed Web of Science ®Google Scholar
• NISSEN SL, ABUMRAD NN: Nutritional role of the leucine metabolite beta-hydroxy-beta-methylbutyrate (HMB). j Num. Biochem. (1997) 8:300–311.
   Web of Science ®Google Scholar
• PANTON LB, RATHMACHER JA, BAIER S, NISSEN S: Nutritional supplementation of the leucine metabolite P-hydroxy-P-methylbutyrate (HMB) during resistance training. Nutrition (2000) 16:734–739.
   PubMed Web of Science ®Google Scholar
• GALLAGHER PM, CARRITHERS JA, GODARD MP, SCHULZE KE, TRAPPE SW: P-hydroxy-P-methylbutyrate ingestion, Part I: effects on strength and fat free mass. Med. Sci. Sports Exerc. (2000) 32:2109–2115.
   PubMed Web of Science ®Google Scholar
• KALMAN D, COLKER CM, WILETS I, ROUFS JB, ANTONIO J: The effects of pyruvate supplementation on body composition in overweight individuals. Nutrition (1999) 15:337–340.
   PubMedGoogle Scholar
• STONE MH, SANBORN K, SMITH LL et al: Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players. Int. J. Sport Num (1999) 9:146–165.
   PubMed Web of Science ®Google Scholar
• MORRISON MA, SPRIET LL, DYCK DJ: Pyruvate ingestion for 7 days does not improve aerobic performance in well- trained individuals. J. Appl. Physiol (2000) 89:549–556.
   PubMedGoogle Scholar
• SEN CK: Antioxidant and redox regulation of cellular signaling: introduction. Med. Sri. Sports Exec (2001) 33:368–370.
   PubMed Web of Science ®Google Scholar
• SEN CK, PACKER L: Thiol homeostasis and supplements in physical exercise. Am. J. OM. Num (2000) 72:653S–669S.
   Google Scholar
• COOMBES JS, POWERS SK, HAMILTON KL etal.: Improved cardiac performance after ischemia in aged rats supplemented with vitamin E and alpha-lipoic acid. Am. J. Physiol. (2000) 279:R2149–R2155.
   Google Scholar
• COOMBES JS, POWERS SK, ROWELL B et al: Effects of vitamin E and a-lipoic acid on skeletal muscle contractile properties. J. Appl. Physiol (2001) 90:1424–1430.
   PubMed Web of Science ®Google Scholar
• POWERS SK, LENNON SL: Analysis of cellular responses to free radicals: focus on exercise and skeletal muscle. Proc. Num. Soc. (1999) 58:1025–1033.
   PubMed Web of Science ®Google Scholar
• REID MB: Redox modulation of skeletal muscle contraction: what we know and what we don't. J. Appl. Physiol (2001) 90:724–731.
   PubMed Web of Science ®Google Scholar
• PLANT DR, GREGOREVIC P, WILLIAMS DA, LYNCH GS: Redox modulation of maximum force production of fast- and slow-twitch skeletal muscles of rats and mice. J. Appl. Physiol. (2001) 90:832–838.
   PubMed Web of Science ®Google Scholar
• BUCK M, CHOJKIER M: Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J. (1996) 15:1753–1765.
   PubMed Web of Science ®Google Scholar
• SEN CK, KHANNA S, REZNICK AZ, ROY S, PACKER L: Glutathione regulation of tumor necrosis factor-a-induced NF-1c13 activation in skeletal muscle-derived L6 cells. Biochem. Biophys. Res. Comm. (1997) 237:645–649.
   PubMed Web of Science ®Google Scholar
• REID MB, LI YP: Tumor necrosis factor-a and muscle wasting: a cellular perspective. Resp. Res. (2001) 2:269–272.
   PubMed Web of Science ®Google Scholar
• RICE CL: Muscle function at the motor unit level: Consequences of aging. Topics Geriat. Rehab. (2000) 15:70–82.
   Google Scholar
• LEXELL J, TAYLOR T. Variability in muscle fiber areas in whole human quadriceps muscle: effects of increasing age. J. Anat. (1991) 174:239–249.
   PubMed Web of Science ®Google Scholar
• WINEINGER MA, SHARMAN RB, STEVENSON TR, CARLSEN RC, McDONALD RB: Peripheral nerve and muscle function in the aging Fischer 344/ Brown Norway rat. Growth Dev Aging (1995) 59:107–119.
   PubMedGoogle Scholar